# CHIMERA (NCT06155279)

> Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06155279
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Istituto Oncologico Veneto IRCCS
- Conditions: Pleural Mesothelioma
- Interventions: Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
- Enrollment: 41
- Primary outcome: Primary endpoint - To evaluate the activity of neo-adjuvant treatment by the determination of pathological complete response rate (pCR)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 3
- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=chimera-nct06155279